Yüklüyor......
Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation
BACKGROUND: Omenn syndrome (OS) is a rare severe combined immunodeficiency associated with autoimmunity and caused by defects in lymphoid-specific V(D)J recombination. Most patients carry hypomorphic mutations in recombination-activating gene (RAG) 1 or 2. Hematopoietic stem cell transplantation is...
Kaydedildi:
| Yayımlandı: | J Allergy Clin Immunol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081264/ https://ncbi.nlm.nih.gov/pubmed/29241731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.11.015 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|